Search
for
Sort by
Research 61–90 of 1000+
- Dermatological adverse events with taxane chemotherapy
- Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases
- Cutaneous manifestations of COVID-19 and vaccines for its prevention: a review of the existing literature
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Adverse cutaneous effects of psychotropic medications
- Contents
- Contents
- Drug-Induced Skin, Nail and Hair Disorders
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- HAIR LOSS ASSOCIATED WITH ESCITALOPRAM: DO SSRIs AFFECT MELATONIN AT THE HAIR FOLLICLE?
- Semaglutide and the Skin: An Overview of Current Evidence
- Cutaneous manifestations associated with immune checkpoint inhibitors
- Severe hair loss associated with psyc hotropic drugs in psychiatric inpatients—Data from an observational pharmacovigilance program in German-speaking countries
- Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients
- Cutaneous complications of chemotherapeutic agents
- Systemic Vasculitis with Severe Cutaneous Manifestation as a Suspected Idiosyncratic Hypersensitivity Reaction to Fenbendazole in a Cat
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Cutaneous lesions and clinical outcomes in five cats after frunevetmab injections
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Harmless Herbs? A Review of the Recent Literature
- Adverse Effects Associated with Long-Term Administration of Azole Antifungal Agents
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- Imported cutaneous Leishmaniasis in Japan
- Adverse Reaction to Cetuximab, an Epidermal Growth Factor Receptor Inhibitor.
- Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database
- Sorafenib-Associated Facial Acneiform Eruption
- Cutaneous Toxicities of Advanced Treatment for Cutaneous Melanoma: A Prospective Study from a Single-Center Institution
- Cemiplimab-Induced Alopecia Areata
- TOC
- Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors